Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C12H15F2NO2 |
| Molecular Weight | 243.2498 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H]1CO[C@](O)([C@H](C)N1)C2=CC(F)=CC(F)=C2
InChI
InChIKey=OZGPVYJHWWPEFT-RGNHYFCHSA-N
InChI=1S/C12H15F2NO2/c1-7-6-17-12(16,8(2)15-7)9-3-10(13)5-11(14)4-9/h3-5,7-8,15-16H,6H2,1-2H3/t7-,8+,12-/m1/s1
| Molecular Formula | C12H15F2NO2 |
| Molecular Weight | 243.2498 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
CNS Activity
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The impact of medications on quality of life in attention-deficit hyperactivity disorder: a systematic review. | 2010-10 |
|
| Pharmacogenetics and obesity: common gene variants influence weight loss response of the norepinephrine/dopamine transporter inhibitor GW320659 in obese subjects. | 2005-12 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12162627
a multicenter, open-label, dose-titration study of seven daily dose levels of manifaxine (GW 320659): 1.25, 2.5, 5, 7.5,10,12.5, and 15 mg.
Route of Administration:
Unknown
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:31:48 GMT 2025
by
admin
on
Wed Apr 02 08:31:48 GMT 2025
|
| Record UNII |
J8IE53G2IV
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29747
Created by
admin on Wed Apr 02 08:31:48 GMT 2025 , Edited by admin on Wed Apr 02 08:31:48 GMT 2025
|
||
|
NCI_THESAURUS |
C66884
Created by
admin on Wed Apr 02 08:31:48 GMT 2025 , Edited by admin on Wed Apr 02 08:31:48 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID60928953
Created by
admin on Wed Apr 02 08:31:48 GMT 2025 , Edited by admin on Wed Apr 02 08:31:48 GMT 2025
|
PRIMARY | |||
|
C81329
Created by
admin on Wed Apr 02 08:31:48 GMT 2025 , Edited by admin on Wed Apr 02 08:31:48 GMT 2025
|
PRIMARY | |||
|
8088
Created by
admin on Wed Apr 02 08:31:48 GMT 2025 , Edited by admin on Wed Apr 02 08:31:48 GMT 2025
|
PRIMARY | |||
|
300000037021
Created by
admin on Wed Apr 02 08:31:48 GMT 2025 , Edited by admin on Wed Apr 02 08:31:48 GMT 2025
|
PRIMARY | |||
|
J8IE53G2IV
Created by
admin on Wed Apr 02 08:31:48 GMT 2025 , Edited by admin on Wed Apr 02 08:31:48 GMT 2025
|
PRIMARY | |||
|
135306-39-7
Created by
admin on Wed Apr 02 08:31:48 GMT 2025 , Edited by admin on Wed Apr 02 08:31:48 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106783
Created by
admin on Wed Apr 02 08:31:48 GMT 2025 , Edited by admin on Wed Apr 02 08:31:48 GMT 2025
|
PRIMARY | |||
|
MANIFAXINE
Created by
admin on Wed Apr 02 08:31:48 GMT 2025 , Edited by admin on Wed Apr 02 08:31:48 GMT 2025
|
PRIMARY | |||
|
60829
Created by
admin on Wed Apr 02 08:31:48 GMT 2025 , Edited by admin on Wed Apr 02 08:31:48 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |